An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Humans
Artificial Intelligence
Fluorodeoxyglucose F18
Lymphoma, Large B-Cell, Diffuse
/ diagnostic imaging
Positron Emission Tomography Computed Tomography
/ methods
Positron-Emission Tomography
Prognosis
Prospective Studies
Retrospective Studies
Tomography, X-Ray Computed
Treatment Outcome
Clinical Trials as Topic
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 08 2023
12 08 2023
Historique:
received:
31
03
2023
accepted:
07
08
2023
medline:
14
8
2023
pubmed:
13
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN using maximum intensity projection (MIP) images from
Identifiants
pubmed: 37573446
doi: 10.1038/s41598-023-40218-1
pii: 10.1038/s41598-023-40218-1
pmc: PMC10423266
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13111Investigateurs
Otto S Hoekstra
(OS)
Coreline N Burggraaff
(CN)
Annelies Bes
(A)
Martijn W Heymans
(MW)
Yvonne W S Jauw
(YWS)
Martine E D Chamuleau
(MED)
Sally F Barrington
(SF)
George Mikhaeel
(G)
Emanuele Zucca
(E)
Luca Ceriani
(L)
Robert Carr
(R)
Tamás Györke
(T)
Sándor Czibor
(S)
Stefano Fanti
(S)
Lale Kostakoglu
(L)
Annika Loft
(A)
Martin Hutchings
(M)
Sze Ting Lee
(ST)
Informations de copyright
© 2023. Springer Nature Limited.
Références
Blood. 2017 Oct 19;130(16):1800-1808
pubmed: 28774879
J Nucl Med. 2020 Jan;61(1):40-45
pubmed: 31201248
Comput Med Imaging Graph. 2017 Sep;60:3-10
pubmed: 27955798
Eur Radiol. 2020 Nov;30(11):6322-6330
pubmed: 32524219
Ann Oncol. 2021 Mar;32(3):404-411
pubmed: 33278600
Ann Nucl Med. 1999 Jun;13(3):199-203
pubmed: 10435383
PLoS Comput Biol. 2016 Apr 28;12(4):e1004896
pubmed: 27124699
Phys Med Biol. 2019 Apr 12;64(8):085019
pubmed: 30818303
J Clin Oncol. 2020 Oct 10;38(29):3377-3387
pubmed: 32730183
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3198-3220
pubmed: 33604689
Blood. 2023 Jun 22;141(25):3055-3064
pubmed: 37001036
Eur J Cancer. 2020 Jan;124:25-36
pubmed: 31710995
Blood. 2022 May 5;139(18):2737-2746
pubmed: 35240677
J Nucl Med. 2022 Dec;63(12):1925-1932
pubmed: 35710733
J Nucl Med. 2022 Sep;63(9):1288-1299
pubmed: 35618476
EJNMMI Res. 2022 Sep 11;12(1):58
pubmed: 36089634
Radiology. 2020 Feb;294(2):445-452
pubmed: 31821122
Br J Haematol. 2021 Feb;192(3):504-513
pubmed: 32621535
J Clin Oncol. 2018 Jul 10;36(20):2024-2034
pubmed: 29750632
Blood Adv. 2021 May 11;5(9):2375-2384
pubmed: 33944897
Eur Radiol. 2020 Aug;30(8):4623-4632
pubmed: 32248365
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3151-3161
pubmed: 33611614
Cancer Inform. 2019 Mar 15;18:1176935119835538
pubmed: 30906191
Cancer Treat Rev. 2022 Jul;108:102410
pubmed: 35609495
J Clin Oncol. 2022 Jul 20;40(21):2352-2360
pubmed: 35357901
EJNMMI Phys. 2020 Dec 14;7(1):76
pubmed: 33315178
J Nucl Med. 2021 Mar;62(3):332-337
pubmed: 32680929
JAMA. 2018 Dec 4;320(21):2199-2200
pubmed: 30398550
Mol Imaging. 2019 Jan-Dec;18:1536012119863531
pubmed: 31364467
EJHaem. 2022 Mar 24;3(2):406-414
pubmed: 35846039
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):932-942
pubmed: 34405277
Cancer Imaging. 2022 Aug 12;22(1):39
pubmed: 35962459
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1362-1370
pubmed: 33097974
Radiol Artif Intell. 2020 Sep 02;2(5):e200016
pubmed: 33937842
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219